171 related articles for article (PubMed ID: 8448243)
21. Increased lung uptake of 99Tcm-sulphur colloid as an early indicator of the development of hepatic veno-occlusive disease in bone marrow transplant patients.
Jacobson AF; Teefey SA; Higano CA; Bianco JA
Nucl Med Commun; 1993 Aug; 14(8):706-11. PubMed ID: 8371897
[TBL] [Abstract][Full Text] [Related]
22. Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide.
Lee JH; Lee KH; Lee JH; Kim S; Seol M; Park CJ; Chi HS; Kang W; Kim ST; Kim WK; Lee JS
Br J Haematol; 2002 Sep; 118(4):1087-94. PubMed ID: 12199790
[TBL] [Abstract][Full Text] [Related]
23. Transient elastography of liver: Could it be a guide for diagnosis and management strategy in hepatic veno-occlusive disease (sinusoidal obstruction syndrome)?
Özkan SG; Pata C; Şekuri A; Çınar Y; Özkan HA
Transfus Apher Sci; 2022 Feb; 61(1):103370. PubMed ID: 35101374
[TBL] [Abstract][Full Text] [Related]
24. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].
Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M
Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053
[TBL] [Abstract][Full Text] [Related]
25. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.
Shulman HM; Fisher LB; Schoch HG; Henne KW; McDonald GB
Hepatology; 1994 May; 19(5):1171-81. PubMed ID: 8175139
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation.
Marsa-Vila L; Gorin NC; Laporte JP; Labopin M; Dupuy-Montbrun MC; Fouillard L; Isnard F; Najman A
Eur J Haematol; 1991 Nov; 47(5):346-54. PubMed ID: 1761121
[TBL] [Abstract][Full Text] [Related]
27. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.
Fried MW; Connaghan DG; Sharma S; Martin LG; Devine S; Holland K; Zuckerman A; Kaufman S; Wingard J; Boyer TD
Hepatology; 1996 Sep; 24(3):588-91. PubMed ID: 8781329
[TBL] [Abstract][Full Text] [Related]
28. Serum procollagen type III is an early and sensitive marker for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Heikinheimo M; Halila R; Fasth A
Blood; 1994 May; 83(10):3036-40. PubMed ID: 8180401
[TBL] [Abstract][Full Text] [Related]
29. The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation.
Salat C; Holler E; Kolb HJ; Pihusch R; Reinhardt B; Penovici M; Ledderose G; Hiller E
Leuk Lymphoma; 1999 Mar; 33(1-2):25-32. PubMed ID: 10194118
[TBL] [Abstract][Full Text] [Related]
30. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
Qureshi A; Marshall L; Lancaster D
Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
[TBL] [Abstract][Full Text] [Related]
31. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
Ozkaynak MF; Weinberg K; Kohn D; Sender L; Parkman R; Lenarsky C
Bone Marrow Transplant; 1991 Jun; 7(6):467-74. PubMed ID: 1908340
[TBL] [Abstract][Full Text] [Related]
32. Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation.
Morio S; Oh H; Hirasawa A; Aotsuka N; Nakamura H; Asai T; Yoshida S; Ito M
Bone Marrow Transplant; 1991 Aug; 8(2):147-9. PubMed ID: 1933057
[TBL] [Abstract][Full Text] [Related]
33. Recent progress in the diagnosis and therapy for veno-occlusive disease of the liver.
Yoshimoto K; Ono N; Okamura T; Sata M
Leuk Lymphoma; 2003 Feb; 44(2):229-34. PubMed ID: 12688338
[TBL] [Abstract][Full Text] [Related]
34. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation.
Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Esperou H; Lehn P; Faure P; Drouet L
Br J Haematol; 1990 Mar; 74(3):277-81. PubMed ID: 2159315
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.
Corbacioglu S; Carreras E; Ansari M; Balduzzi A; Cesaro S; Dalle JH; Dignan F; Gibson B; Guengoer T; Gruhn B; Lankester A; Locatelli F; Pagliuca A; Peters C; Richardson PG; Schulz AS; Sedlacek P; Stein J; Sykora KW; Toporski J; Trigoso E; Vetteranta K; Wachowiak J; Wallhult E; Wynn R; Yaniv I; Yesilipek A; Mohty M; Bader P
Bone Marrow Transplant; 2018 Feb; 53(2):138-145. PubMed ID: 28759025
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
[TBL] [Abstract][Full Text] [Related]
37. Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive disease after stem cell transplantation.
Gerecitano J; Mathias C; Mick R; Duffy KM; Luger S; Stadtmauer EA; Schuster SJ; Tsai D; Nasta S; Berlin J; Phillips DK; High KA; Porter DL
J Hematother Stem Cell Res; 2003 Apr; 12(2):215-23. PubMed ID: 12804180
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution.
Kami M; Mori S; Tanikawa S; Akiyama H; Onozawa Y; Tanaka T; Okamoto R; Maeda Y; Sasaki T; Kaku H; Matsuura Y; Hiruma K; Sakamaki H
Bone Marrow Transplant; 1997 Sep; 20(5):397-402. PubMed ID: 9339756
[TBL] [Abstract][Full Text] [Related]
39. Venoocclusive disease of the liver following bone marrow transplantation.
Jones RJ; Lee KS; Beschorner WE; Vogel VG; Grochow LB; Braine HG; Vogelsang GB; Sensenbrenner LL; Santos GW; Saral R
Transplantation; 1987 Dec; 44(6):778-83. PubMed ID: 3321587
[TBL] [Abstract][Full Text] [Related]
40. Plasma levels of D-dimer and circulating endothelial adhesion molecules in veno-occlusive disease of the liver following allogeneic bone marrow transplantation.
Südhoff T; Heins M; Söhngen D; Lenz V; Wehmeier A; Aul C; Meckenstock G; Schneider W; Reinauer H; Heyll A
Eur J Haematol; 1998 Feb; 60(2):106-11. PubMed ID: 9508351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
